Are There More HER2 FISH in the Sea? An Institution’s Experience in Identifying HER2 Positivity Using Fluorescent In Situ Hybridization in Patients with HER2 Negative Immunohistochemistry

BACKGROUND: Approximately 20% of breast cancers express HER2-positive receptors in the USA. HER2 receptor immunohistochemistry (IHC) staining with equivocal (2+) results commonly undergoes fluorescence in-situ hybridization (FISH) for further classification. Current guidelines do not recommend routi...

Descripción completa

Detalles Bibliográficos
Autores principales: Suydam, Camille, Chibane, Fairouz, Brown, Nicole, Schlafly, Madeleine, Arnold, Alicia H., Ghleilib, Intisar, Easley, Melissa, White, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695864/
https://www.ncbi.nlm.nih.gov/pubmed/37936021
http://dx.doi.org/10.1245/s10434-023-14439-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695864/
https://www.ncbi.nlm.nih.gov/pubmed/37936021
http://dx.doi.org/10.1245/s10434-023-14439-7

Ejemplares similares